Baxter Healthcare Corporation vs INTERVASCULAR, SAS: FDA Enforcement Comparison

Baxter Healthcare Corporation has been the subject of 235 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for INTERVASCULAR, SAS.

Baxter Healthcare Corporation: 0 warning letters, 235 recalls, 0 approval records, 0 Form 483s.

INTERVASCULAR, SAS: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.

Side by side

Baxter Healthcare Corporation — Warning letters0

INTERVASCULAR, SAS — Warning letters0

Baxter Healthcare Corporation — Recalls235

INTERVASCULAR, SAS — Recalls1

Baxter Healthcare Corporation — Approval records0

INTERVASCULAR, SAS — Approval records0

Baxter Healthcare Corporation — Form 483s0

INTERVASCULAR, SAS — Form 483s0

Timeline

Baxter Healthcare Corporation

Most recent FDA action: September 30, 2026

Full history →

INTERVASCULAR, SAS

Most recent FDA action: September 30, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Baxter Healthcare Corporation vs INTERVASCULAR, SAS: FDA Enforcement Comparison." Argus HQ, accessed October 12, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-intervascular-sas

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗